Biktatvy raw powder is a new type of AIDS drug with lower side effects, better drug resistance than similar products, and ease to use. Its composition is (Bictegravir 50mg/emtricitabine 200mg/Tenofovir Alafenamide 25mg).
In a clinical application in China, Biktatvy is applicable to adults infected with human immunodeficiency virus type 1 (HIV-1) as a complete treatment scheme, and the patients have no evidence of viral resistance to integrase inhibitors, Emtricitabine or tenofovir at present and in the past. Adults and children who weigh at least 55 pounds (more than 25 kilograms).
Why do many hospitals now choose this product as the main HIV blocker?
The first is the price advantage. A high price is the most significant pain point of imported drugs. Thanks to the national policy, the price of this product, as an outstanding anti-AIDS drug, has plummeted. For example, Truvada is several times more than Biktarvy.
Secondly, the highly effective antiviral effect, not only as an antiviral drug for AIDS but also for the blocking effect, the structural innovation of Bictegravir (BIC) in this product can effectively and persistently inhibit HIV replication. People in need of different ages can use Biktatvy RAW MATERIAL for HIV antiviral treatment. At present, most of them will choose this drug for emergency blocking after HIV exposure. The golden 72 hours are effective, and the earlier the blocking effect is, the better.
Third, this product is a compound single tablet, and it is the smallest triple compound single tablet among the existing integrase inhibitors. The convenience of "once a day, one tablet at a time" is good news for many patients. Different from the need to take multiple tablets every day in the past, a single tablet can provide better medication compliance, which is convenient to help the infected demanders adhere to treatment or block after a high-risk exposure.
The fourth point is that the drug resistance barrier of this product is high. The 48-week observation results show that the treatment group has reached the main virological endpoint of non-inferiority, and no subjects have the virological resistance caused by treatment in the treatment group.
The fifth point is to improve the toxic and side effects of this product. The compound single tablet can not only achieve a good virus inhibition effect but also effectively reduce the toxic and side effects caused by the use of drugs. However, it is important to note that some drugs or foods can not be taken together with the product. For example, multi-valent ionic drugs (magnesium, aluminum, calcium) are taken together. If you need to take it, you should take it two hours before and after Biktarvy. It is forbidden to use it in combination with Tikosyn or RFP, and it is not recommended to use it together with alcoholic beverages.
The information in this article comes from the Internet and is not used as treatment advice or investment advice. If this article has an impact on your rights and interests or is interested in this product, please contact us in time so that we can provide you with more help